Your browser doesn't support javascript.
loading
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations.
Sonneveld, Nicole; Stanojevic, Sanja; Amin, Reshma; Aurora, Paul; Davies, Jane; Elborn, J Stuart; Horsley, Alex; Latzin, Philipp; O'Neill, Katherine; Robinson, Paul; Scrase, Emma; Selvadurai, Hiran; Subbarao, Padmaja; Welsh, Liam; Yammine, Sophie; Ratjen, Felix.
Affiliation
  • Sonneveld N; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada Both authors contributed equally.
  • Stanojevic S; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada Physiology and Experimental Medicine, Research Institute, Hospital for Sick Children, Toronto, ON, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada Both authors c
  • Amin R; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
  • Aurora P; Great Ormond Street Hospital, London, UK.
  • Davies J; Royal Brompton Hospital, London, UK.
  • Elborn JS; Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Horsley A; Institute of Inflammation and Repair, University of Manchester, Manchester, UK.
  • Latzin P; University Children's Hospital Bern, Bern, Switzerland University Children's Hospital Basel (UKBB), Basel, Switzerland.
  • O'Neill K; Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
  • Robinson P; Dept of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, Australia Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Scrase E; Great Ormond Street Hospital, London, UK.
  • Selvadurai H; Dept of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, Australia Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Subbarao P; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada Physiology and Experimental Medicine, Research Institute, Hospital for Sick Children, Toronto, ON, Canada Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
  • Welsh L; Royal Children's Hospital, Melbourne, Australia Murdoch Children's Research Institute, Melbourne, Australia.
  • Yammine S; University Children's Hospital Bern, Bern, Switzerland University Children's Hospital Basel (UKBB), Basel, Switzerland.
  • Ratjen F; Division of Respiratory Medicine, Hospital for Sick Children, Toronto, ON, Canada Physiology and Experimental Medicine, Research Institute, Hospital for Sick Children, Toronto, ON, Canada Faculty of Medicine, Dept of Paediatrics, University of Toronto, Toronto, ON, Canada.
Eur Respir J ; 46(4): 1055-64, 2015 Oct.
Article in En | MEDLINE | ID: mdl-26160868

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Lung / Anti-Bacterial Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Eur Respir J Year: 2015 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Lung / Anti-Bacterial Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Eur Respir J Year: 2015 Type: Article